{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:41:48Z","timestamp":1791384108795,"version":"4.3.3"},"reference-count":93,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2025,2,28]]},"DOI":"10.5582\/bst.2024.01352","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T22:10:58Z","timestamp":1737756658000},"page":"87-101","source":"Crossref","is-referenced-by-count":9,"title":["Intestinal microbiota distribution and changes in different stages of Parkinson's disease: A meta-analysis, bioinformatics analysis and <i>in vivo<\/i> simulation"],"prefix":"10.5582","volume":"19","author":[{"given":"Tingyue","family":"Jiang","sequence":"first","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Fan","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Li","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzhi","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Shi","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967; 17:427-442.","DOI":"10.1212\/WNL.17.5.427"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L, Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004; 19:1020-1028.","DOI":"10.1002\/mds.20213"},{"key":"3","unstructured":"3. Chinese Society of Parkinson's Disease and Movement Disorders, Parkinson's Disease and Movement Disorder Section of Neurologist Branch of Chinese Medical Doctor Association. Chinese guidelines for the treatment of Parkinson's disease (fourth edition). Chinese Journal of Neurology. 2020; 53:973-986. (in Chinese)"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Zhuang M, Zhang X, Cai J. Microbiota-gut-brain axis: interplay between microbiota, barrier function and lymphatic system. Gut Microbes. 2024; 16:2387800.","DOI":"10.1080\/19490976.2024.2387800"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nuzum ND, Deady C, Kittel-Schneider S, Cryan JF, O'Mahony SM, Clarke G. More than just a number: the gut microbiota and brain function across the extremes of life. Gut Microbes. 2024; 16:2418988.","DOI":"10.1080\/19490976.2024.2418988"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dom\u00ednguez Rojo N, Blanco Ben\u00edtez M, Cava R, Fuentes JM, Canales Cort\u00e9s S, Gonz\u00e1lez Polo RA. Convergence of neuroinflammation, microbiota, and Parkinson's disease: Therapeutic insights and prospects. Int J Mol Sci. 2024; 25:11629.","DOI":"10.3390\/ijms252111629"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Zhao Z, Chen J, Zhao D, Chen B, Wang Q, Li Y, Chen J, Bai C, Guo X, Hu N, Zhang B, Zhao R, Yuan J. Microbial biomarker discovery in Parkinson's disease through a network-based approach. NPJ Parkinsons Dis. 2024; 10:203.","DOI":"10.1038\/s41531-024-00802-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z. Gut microbiota: A novel therapeutic target for Parkinson's disease. Front Immunol. 2022; 13:937555.","DOI":"10.3389\/fimmu.2022.937555"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc. 2007; 2:141-151.","DOI":"10.1038\/nprot.2006.342"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Madiha S, Batool Z, Shahzad S, Tabassum S, Liaquat L, Afzal A, Sadir S, Sajid I, Mehdi BJ, Ahmad S, Haider S. Naringenin, a functional food component, improves motor and non-motor symptoms in animal model of parkinsonism induced by rotenone. Plant Foods Hum Nutr. 2023; 78:654-661.","DOI":"10.1007\/s11130-023-01103-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Haider S, Madiha S, Batool Z. Amelioration of motor and non-motor deficits and increased striatal APoE levels highlight the beneficial role of pistachio supplementation in rotenone-induced rat model of PD. Metab Brain Dis. 2020; 35:1189-1200.","DOI":"10.1007\/s11011-020-00584-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sharma S, Kumar P, Deshmukh R. Neuroprotective potential of spermidine against rotenone induced Parkinson's disease in rats. Neurochem Int. 2018; 116:104-111.","DOI":"10.1016\/j.neuint.2018.02.010"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Liu X, Du ZR, Wang X, Luk KH, Chan CH, Cao X, Zhao Q, Zhao F, Wong WT, Wong KH, Dong XL. Colonic dopaminergic neurons changed reversely with those in the midbrain via<\/i> gut microbiota-mediated autophagy in a chronic Parkinson's disease mice model. Front Aging Neurosci. 2021; 13:649627.","DOI":"10.3389\/fnagi.2021.649627"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hu XM, Song LZ, Zhang ZZ, Ruan X, Li HC, Yu Z, Huang L. Electroacupuncture at ST25 corrected gut microbial dysbiosis and SNpc lipid peroxidation in Parkinson's disease rats. Front Microbiol. 2024; 15:1358525.","DOI":"10.3389\/fmicb.2024.1358525"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Eo H, Yu SH, Choi Y, Kim Y, Kang YC, Lee H, Kim JH, Han K, Lee HK, Chang MY, Oh MS, Kim CH. Mitochondrial transplantation exhibits neuroprotective effects and improves behavioral deficits in an animal model of Parkinson's disease. Neurotherapeutics. 2024; 21:e00355.","DOI":"10.1016\/j.neurot.2024.e00355"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gao L, Cao M, Du GH, Qin XM. Huangqin decoction exerts beneficial effects on rotenone-induced rat model of Parkinson's disease by improving mitochondrial dysfunction and alleviating metabolic abnormality of mitochondria. Front Aging Neurosci. 2022; 14:911924.","DOI":"10.3389\/fnagi.2022.911924"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kerdiles O, Oye Mintsa Mi-Mba MF, Coulombe K, Tremblay C, \u00c9mond V, Saint-Pierre M, Rouxel C, Berthiaume L, Julien P, Cicchetti F, Calon F. Additive neurorestorative effects of exercise and docosahexaenoic acid intake in a mouse model of Parkinson's disease. Neural Regen Res. 2025; 20:574-586.","DOI":"10.4103\/NRR.NRR-D-23-00595"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Jiang W, Cheng Y, Wang Y, Wu J, Rong Z, Sun L, Zhou Y, Zhang K. Involvement of abnormal p-\u03b1-syn accumulation and TLR2-mediated inflammation of Schwann cells in enteric autonomic nerve dysfunction of Parkinson's disease: an animal model study. Mol Neurobiol. 2023; 60:4738-4752.","DOI":"10.1007\/s12035-023-03345-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Aho VTE, Pereira PAB, Voutilainen S, Paulin L, Pekkonen E, Auvinen P, Scheperjans F. Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression. EBioMedicine. 2019; 44:691-707.","DOI":"10.1016\/j.ebiom.2019.05.064"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Babacan Yildiz G, Kayacan ZC, Karacan I, Sumbul B, Elibol B, Gelisin O, Akgul O. Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study. Acta Neurol Belg. 2023; 123:999-1009.","DOI":"10.1007\/s13760-023-02195-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Barichella M, Severgnini M, Cilia R, et al<\/i>. Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism. Mov Disord. 2019; 34:396-405.","DOI":"10.1002\/mds.27581"},{"key":"22","unstructured":"22. Bi ZA. Analysis of gut microbiota in patients with Parkinson's disease. Nanjing Medical University. 2018. (in Chinese)"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Bolliri C, Fontana A, Cereda E, Barichella M, Cilia R, Ferri V, Caronni S, Calandrella D, Morelli L, Pezzoli G. Gut microbiota in monozygotic twins discordant for Parkinson's disease. Ann Neurol. 2022; 92:631-636.","DOI":"10.1002\/ana.26454"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Cerroni R, Pietrucci D, Teofani A, Chillemi G, Liguori C, Pierantozzi M, Unida V, Selmani S, Mercuri NB, Stefani A. Not just a snapshot: An Italian longitudinal evaluation of stability of gut microbiota findings in Parkinson's disease. Brain Sci. 2022; 12:739.","DOI":"10.3390\/brainsci12060739"},{"key":"25","unstructured":"25. Chen H. Diversity of intestinal microflora in patients with Parkinson's disease. Jinan University. 2017. (in Chinese)"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Cirstea MS, Yu AC, Golz E, Sundvick K, Kliger D, Radisavljevic N, Foulger LH, Mackenzie M, Huan T, Finlay BB, Appel-Cresswell S. Microbiota composition and metabolism are associated with gut function in Parkinson's disease. Mov Disord. 2020; 35:1208-1217.","DOI":"10.1002\/mds.28052"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov Disord. 2017; 32:739-749.","DOI":"10.1002\/mds.26942"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Li F, Wang P, Chen Z, Sui X, Xie X, Zhang J. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease. Neurosci Lett. 2019; 707:134297.","DOI":"10.1016\/j.neulet.2019.134297"},{"key":"29","unstructured":"29. Li KS. Multi-center Clinical observation of acupuncture intervention of Parkinson's disease and its effect on intestinal microbiome, short chain fatty acid. Shanghai University of Traditional Chinese Medicine. 2020. (in Chinese)"},{"key":"30","unstructured":"30. Li T. The relationship between TCM syndrome and clinical stage, substantia nigra change and intestinal flora of Parkinson's disease. Beijing University of Chinese Medicine. 2020. (in Chinese)"},{"key":"31","unstructured":"31. Li Y, Li RX, Du YT, Xu XJ, Xue Y, Gao D, Gao T, Sheng Z, Zhang LY, Tuo HZ. Features of gut microbiota in patients with idiopathic Parkinson's disease. National Medical Journal of China. 2020; 100:1017-1022. (in Chinese)"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lin A, Zheng W, He Y, Tang W, Wei X, He R, Huang W, Su Y, Huang Y, Zhou H, Xie H. Gut microbiota in patients with Parkinson's disease in southern China. Parkinsonism Relat Disord. 2018; 53:82-88.","DOI":"10.1016\/j.parkreldis.2018.05.007"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Mao L, Zhang Y, Tian J, Sang M, Zhang G, Zhou Y, Wang P. Cross-Sectional study on the gut microbiome of Parkinson's disease patients in central China. Front Microbiol. 2021; 12:728479.","DOI":"10.3389\/fmicb.2021.728479"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Nakahara K, Nakane S, Ishii K, Ikeda T, Ando Y. Gut microbiota of Parkinson's disease in an appendectomy cohort: a preliminary study. Sci Rep. 2023; 13:2210.","DOI":"10.1038\/s41598-023-29219-2"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Pietrucci D, Cerroni R, Unida V, Farcomeni A, Pierantozzi M, Mercuri NB, Biocca S, Stefani A, Desideri A. Dysbiosis of gut microbiota in a selected population of Parkinson's patients. Parkinsonism Relat Disord. 2019; 65:124-130.","DOI":"10.1016\/j.parkreldis.2019.06.003"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Qian Y, Yang X, Xu S, Huang P, Li B, Du J, He Y, Su B, Xu LM, Wang L, Huang R, Chen S, Xiao Q. Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease. Brain. 2020; 143:2474-2489.","DOI":"10.1093\/brain\/awaa201"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Ren T, Gao Y, Qiu Y, Jiang S, Zhang Q, Zhang J, Wang L, Zhang Y, Wang L, Nie K. Gut microbiota altered in mild cognitive impairment compared with normal cognition in sporadic Parkinson's disease. Front Neurol. 2020; 11:137.","DOI":"10.3389\/fneur.2020.00137"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord. 2015; 30:350-358.","DOI":"10.1002\/mds.26069"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Tan AH, Chong CW, Lim SY, Yap IKS, Teh CSJ, Loke MF, Song SL, Tan JY, Ang BH, Tan YQ, Kho MT, Bowman J, Mahadeva S, Yong HS, Lang AE. Gut microbial ecosystem in Parkinson's disease: New clinicobiological insights from multi-omics. Ann Neurol. 2021; 89:546-559.","DOI":"10.1002\/ana.25982"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Tetz G, Brown SM, Hao Y, Tetz V. Parkinson's disease and bacteriophages as its overlooked contributors. Sci Rep. 2018; 8:10812.","DOI":"10.1038\/s41598-018-29173-4"},{"key":"41","unstructured":"41. Tong QW, Chen YF, Wu SX, Zheng LF, Chen YY, Feng M, Ye H. Relationship between gut microbiota and clinical symptoms in patients with Parkinson's disease. Zhejiang Medical Journal. 2021; 43:1085-1090. (in Chinese)"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Vascellari S, Palmas V, Melis M, et al<\/i>. Gut microbiota and metabolome alterations associated with Parkinson's disease. mSystems. 2020; 5:e00561-20.","DOI":"10.1128\/mSystems.00561-20"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Wallen ZD, Demirkan A, Twa G, Cohen G, Dean MN, Standaert DG, Sampson TR, Payami H. Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms. Nat Commun. 2022; 13:6958.","DOI":"10.1038\/s41467-022-34667-x"},{"key":"44","unstructured":"44. Wang YJ. Alterations of intestinal flora and its relationship with intestinal features in Parkinson's disease patients. ZHENGZHOU UNIVERSITY. 2022. (in Chinese)"},{"key":"45","unstructured":"45. Zhang F. Gut microbiota diversity analysis and biomarker identification in patients with Parkinson's disease. Hubei University of Medicine. 2020. (in Chinese)"},{"key":"46","unstructured":"46. Zhang F, Fang X, Xu ML, Zhang Y, Gao P, Zhao Q, Sun XD, Sang M, Wang PQ. The changed abundance of intestinal Prevotella_copri and its predictive value in patients with Parkinson's disease. Journal of Medical Research & Combat Trauma Care. 2020; 33:482-486. (in Chinese)"},{"key":"47","unstructured":"47. Zhang LN, Ye M, Shi P, Yin L, Li QQ, Lu L. Structural characteristics of intestinal flora in patients with Parkinson's disease. Diet Health. 2021; 27:27. (in Chinese)"},{"key":"48","unstructured":"48. Zhang TQ. The characteristics of intestinal flora in Parkinson's disease and the curative effect of Shengqing Jiangzhuo prescription on constipation. Beijing University of Chinese Medicine. 2019. (in Chinese)"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Zhao C, Yu HY, Li W, Shi J, Qin B. Structural changes of gut microbiota in patients with Parkinson's disease. Chinese Journal of Neurology. 2018; 51:498-503. (in Chinese)","DOI":"10.1080\/10971475.2018.1481007"},{"key":"50","unstructured":"50. Zhuo WY. Changes of intestinal flora and SNCA gene polymorphism in patients with Parkinson's disease. Jinan University. 2018. (in Chinese)"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Aktas B. Gut microbial alteration in MPTP mouse model of Parkinson's disease is administration regimen dependent. Cell Mol Neurobiol. 2023; 43:2815-2829.","DOI":"10.1007\/s10571-023-01319-7"},{"key":"52","unstructured":"52. An YY. Resveratrol ameliorates the symptoms of Parkinson's disease mouse and its effect on gut microbiota. Xinxiang Medical University. 2019. (in Chinese)"},{"key":"53","unstructured":"53. An YY, Wu MN, Li PZ, Jing XR, Zhang JF, Xue HF, Deng BG, Zhong GS. Effect of oral administration of streptomycin sulfate on symptoms and gut microbiota of Parkinson's disease mice. Acta Microbiologica Sinica. 2019; 59:1636-1650. (in Chinese)"},{"key":"54","unstructured":"54. Chen XX, Wang T, Zhang T. MPTP-induced intestinal flora and brain inflammation in a mouse model of chronic Parkinson's disease. Chinese Journal of Gerontology. 2022; 42:4031-4035. (in Chinese)"},{"key":"55","unstructured":"55. Chen XX, Wang T, Zhang T. Effects of fecal bacteria transplantation on inflammation of substantia nigra in mice with chronic Parkinson's disease. Chinese Journal of Gerontology. 2022; 42:4778-4783. (in Chinese)"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Dong XL, Wang X, Liu F, Liu X, Du ZR, Li RW, Xue CH, Wong KH, Wong WT, Zhao Q, Tang QJ. Polymannuronic acid prevents dopaminergic neuronal loss via<\/i> brain-gut-microbiota axis in Parkinson's disease model. Int J Biol Macromol. 2020; 164:994-1005.","DOI":"10.1016\/j.ijbiomac.2020.07.180"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Jang JH, Yeom MJ, Ahn S, Oh JY, Ji S, Kim TH, Park HJ. Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease. Brain Behav Immun. 2020; 89:641-655.","DOI":"10.1016\/j.bbi.2020.08.015"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Jeon H, Bae CH, Lee Y, Kim HY, Kim S. Korean red ginseng suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced inflammation in the substantia nigra and colon. Brain Behav Immun. 2021; 94:410-423.","DOI":"10.1016\/j.bbi.2021.02.028"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Liao JF, Cheng YF, You ST, Kuo WC, Huang CW, Chiou JJ, Hsu CC, Hsieh-Li HM, Wang S, Tsai YC. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson's disease. Brain Behav Immun. 2020; 90:26-46.","DOI":"10.1016\/j.bbi.2020.07.036"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Liu MM, Zhou N, Jiang N, Lu KM, Wu CF, Bao JK. Neuroprotective effects of oligosaccharides from Periplaneta Americana on Parkinson's disease models in vitro<\/i> and in vivo<\/i>. Front Pharmacol. 2022; 13:936818.","DOI":"10.3389\/fphar.2022.936818"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Liu X, LiuS, Tang Y, Pu Z, Xiao H, Gao J, Yin Q, Jia Y, Bai Q. Intragastric administration of casein leads to nigrostriatal disease progressed accompanied with persistent nigrostriatal-intestinal inflammation activited and intestinal microbiota-metabolic disorders induced in MPTP mouse model of Parkinson's disease. Neurochem Res. 2021; 46:1514-1539.","DOI":"10.1007\/s11064-021-03293-2"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Liu X, Du ZR, Wang X, Luk KH, Chan CH, Cao X, Zhao Q, Zhao F, Wong WT, Wong KH, Dong XL. Colonic dopaminergic neurons changed reversely with those in the midbrain via<\/i> gut microbiota-mediated autophagy in a chronic Parkinson's disease mice model. Front Aging Neurosci. 2021; 13:649627.","DOI":"10.3389\/fnagi.2021.649627"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Liu X, Du ZR, Wang X, Sun XR, Zhao Q, Zhao F, Wong WT, Wong KH, Dong XL. Polymannuronic acid prebiotic plus Lacticaseibacillus rhamnosus GG probiotic as a novel synbiotic promoted their separate neuroprotection against Parkinson's disease. Food Res Int. 2022; 155:111067.","DOI":"10.1016\/j.foodres.2022.111067"},{"key":"64","unstructured":"64. Shi Y. 5-HT4 receptor antagonist exacerbates neuropathology via<\/i> gut-brain axis in Parkinson's disease mice. JIANGNAN UNIVERSITY. 2021. (in Chinese)"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Sun MF, Zhu YL, Zhou ZL, Jia XB, Xu YD, Yang Q, Cui C, Shen YQ. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway. Brain Behav Immun. 2018; 70:48-60.","DOI":"10.1016\/j.bbi.2018.02.005"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Sun Z, Gu P, Xu H, Zhao W, Zhou Y, Zhou L, Zhang Z, Wang W, Han R, Chai X, An S. Human umbilical cord mesenchymal stem cells improve locomotor function in Parkinson's disease mouse model through regulating intestinal microorganisms. Front Cell Dev Biol. 2022; 9:808905.","DOI":"10.3389\/fcell.2021.808905"},{"key":"67","unstructured":"67. Zhang LY. Based on gut microbes to study the effect of "anti-Parkinson granule" on improving the behavior and constipation of Parkinson's model mice. SHUTCM. 2020. (in Chinese)"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Weis S, Schwiertz A, Unger MM, Becker A, Fa\u00dfbender K, Ratering S, Kohl M, Schnell S, Sch\u00e4fer KH, Egert M. Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota. NPJ Parkinsons Dis. 2019; 5:28.","DOI":"10.1038\/s41531-019-0100-x"},{"key":"69","unstructured":"69. Feng W. Research progress on the involvement of intestinal microbes in the occurrence and development of Parkinson's disease. Chinese Journal of Practical Nervous Diseases. 2024; 27:504-507. (in Chinese)"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Akyaz\u0131 O, Korkmaz D, Cevher SC. Experimental Parkinson models and green chemistry approach. Behav Brain Res. 2024; 471:115092.","DOI":"10.1016\/j.bbr.2024.115092"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Bisbal M, Sanchez M. Neurotoxicity of the pesticide rotenone on neuronal polarization: a mechanistic approach. Neural Regen Res. 2019; 14:762-766.","DOI":"10.4103\/1673-5374.249847"},{"key":"72","unstructured":"72. Meng JL, Liang JF, Zhang XB, Wen MJ, Deng XY. Research progress and evaluation on animal models of Parkinson's disease. Acta Laboratorium Animalis Scientia Sinica. 2021; 29:399-404. (in Chinese)"},{"key":"73","unstructured":"73. Mao ML, Guan YR, Yan YM, Li T, Wang D. Discussion on the best modeling method of rotenone-induced Parkinson's disease model. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease. 2022; 20:1611-1616. (in Chinese)"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Dovonou A, Bolduc C, Soto Linan V, Gora C, Peralta Iii MR, L\u00e9vesque M. Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions. Transl Neurodegener. 2023; 12:36.","DOI":"10.1186\/s40035-023-00368-8"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Zhang QS, Heng Y, Mou Z, Huang JY, Yuan YH, Chen NH. Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease. Acta Pharmacol Sin. 2017; 38:1317-1328.","DOI":"10.1038\/aps.2017.49"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Han X, Liu Y, Dai Y, Xu T, Hu Q, Yi X, Rui L, Hu G, Hu J. Neuronal SH2B1 attenuates apoptosis in an MPTP mouse model of Parkinson's disease via<\/i> promoting PLIN4 degradation. Redox Biol. 2022; 52:102308.","DOI":"10.1016\/j.redox.2022.102308"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Davey LE, Malkus PN, Villa M, Dolat L, Holmes ZC, Letourneau J, Ansaldo E, David LA, Barton GM, Valdivia RH. A genetic system for Akkermansia muciniphila reveals a role for mucin foraging in gut colonization and host sterol biosynthesis gene expression. Nat Microbiol. 2023; 8:1450-1467.","DOI":"10.1038\/s41564-023-01407-w"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Bonnech\u00e8re B, Amin N, van Duijn C. What are the key gut microbiota involved in neurological diseases? A systematic review. Int J Mol Sci. 2022; 23:13665.","DOI":"10.3390\/ijms232213665"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Chiantera V, Lagan\u00e0 AS, Basciani S, Nordio M, Bizzarri M. A critical perspective on the supplementation of Akkermansia muciniphila: benefits and harms. Life (Basel). 2023; 13:1247.","DOI":"10.3390\/life13061247"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Qiao CM, Huang WY, Zhou Y, Quan W, Niu GY, Li T, Zhang MX, Wu J, Zhao LP, Zhao WJ, Cui C, Shen YQ. Akkermansia muciniphila is beneficial to a mouse model of Parkinson's disease, via<\/i> alleviated neuroinflammation and promoted neurogenesis, with involvement of SCFAs. Brain Sci. 2024; 14:238.","DOI":"10.3390\/brainsci14030238"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Khan S, Waliullah S, Godfrey V, Khan MAW, Ramachandran RA, Cantarel BL, Behrendt C, Peng L, Hooper LV, Zaki H. Dietary simple sugars alter microbial ecology in the gut and promote colitis in mice. Sci Transl Med. 2020; 12:eaay6218.","DOI":"10.1126\/scitranslmed.aay6218"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Shkoporov AN, Chaplin AV, Khokhlova EV, Shcherbakova VA, Motuzova OV, Bozhenko VK, Kafarskaia LI, Efimov BA. Alistipes inops sp. nov. and Coprobacter secundus sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2015; 65:4580-4588.","DOI":"10.1099\/ijsem.0.000617"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Kaur H, Das C, Mande SS. In silico<\/i> analysis of putrefaction pathways in bacteria and its implication in colorectal cancer. Front Microbiol. 2017; 8:2166.","DOI":"10.3389\/fmicb.2017.02166"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. The Genus Alistipes: Gut bacteria with emerging implications to inflammation, Cancer, and Mental Health. Front Immunol. 2020; 11:906.","DOI":"10.3389\/fimmu.2020.00906"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Bai F, You L, Lei H, Li X. Association between increased and decreased gut microbiota abundance and Parkinson's disease: A systematic review and subgroup meta-analysis. Exp Gerontol. 2024; 191:112444.","DOI":"10.1016\/j.exger.2024.112444"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Li J, Ni Y, Huang L, Yu X, Zhu J. Er-Bai-Tang decoction improved the movement disorders and neuronal injury in the Parkinson's disease model rats via<\/i> decreasing p38 MAPK pathway and improving the composition of intestinal flora. Acta Cir Bras. 2023; 37:e371104.","DOI":"10.1590\/acb371104"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Qian Y, Yang X, Xu S, Wu C, Song Y, Qin N, Chen SD, Xiao Q. Alteration of the fecal microbiota in Chinese patients with Parkinson's disease. Brain Behav Immun. 2018; 70:194-202.","DOI":"10.1016\/j.bbi.2018.02.016"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Li Z, Liang H, Hu Y, et al<\/i>. Gut bacterial profiles in Parkinson's disease: A systematic review. CNS Neurosci Ther. 2023; 29:140-157.","DOI":"10.1111\/cns.13990"},{"key":"89","unstructured":"89. Zhang H. Correlation analysis between Parkinson's disease and intestinal flora. Henan University. 2023. (in Chinese)"},{"key":"90","unstructured":"90. Zhao ZF. The study of brain dopamine transporter, the level of proBDNF in serum and intestinal flora's changes in patients with Parkinson's disease. Army Medical University. 2019. (in Chinese)"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Li Z, Lu G, Li Z, et al<\/i>. Altered actinobacteria and firmicutes phylum associated epitopes in patients with Parkinson's disease. Front Immunol. 2021; 12:632482.","DOI":"10.3389\/fimmu.2021.632482"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Lubomski M, Xu X, Holmes AJ, Muller S, Yang JYH, Davis RL, Sue CM. The gut microbiome in Parkinson's disease: A longitudinal study of the impacts on disease progression and the use of device-assisted therapies. Front Aging Neurosci. 2022; 14:875261.","DOI":"10.3389\/fnagi.2022.875261"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Lai F, Jiang R, Xie W, Liu X, Tang Y, Xiao H, Gao J, Jia Y, Bai Q. Intestinal pathology and gut microbiota alterations in a methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Neurochem Res. 2018; 43:1986-1999.","DOI":"10.1007\/s11064-018-2620-x"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/19\/1\/19_2024.01352\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T04:17:27Z","timestamp":1741407447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/19\/1\/19_2024.01352\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2024.01352","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"article-number":"2024.01352"}}